open access

Ahead of print
Letter to the Editors
Published online: 2020-10-05
Submitted: 2020-07-19
Accepted: 2020-09-07
Get Citation

Botulinum toxin in the treatment of intestinal pseudo-obstruction following a stroke

Przemysław Nowak, Agnieszka Gala-Błądzińska, Katarzyna Stybel, Rafał Filip
DOI: 10.5603/PJNNS.a2020.0073
·
Pubmed: 33026647

open access

Ahead of print
Letter to the Editors
Published online: 2020-10-05
Submitted: 2020-07-19
Accepted: 2020-09-07

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

botulinum toxin, constipation, external anal sphincter, spasticity

About this article
Title

Botulinum toxin in the treatment of intestinal pseudo-obstruction following a stroke

Journal

Neurologia i Neurochirurgia Polska

Issue

Ahead of print

Published online

2020-10-05

DOI

10.5603/PJNNS.a2020.0073

Pubmed

33026647

Keywords

botulinum toxin
constipation
external anal sphincter
spasticity

Authors

Przemysław Nowak
Agnieszka Gala-Błądzińska
Katarzyna Stybel
Rafał Filip

References (10)
  1. Fonfria E, Maignel J, Lezmi S, et al. The Expanding Therapeutic Utility of Botulinum Neurotoxins. Toxins (Basel). 2018; 10(5).
  2. Brisinda G, Sivestrini N, Bianco G, et al. Treatment of gastrointestinal sphincters spasms with botulinum toxin A. Toxins (Basel). 2015; 7(6): 1882–1916.
  3. Madaliński MH, Sławek J, Duzyński W, et al. Side effects of botulinum toxin injection for benign anal disorders. European Journal of Gastroenterology & Hepatology. 2002;14. ; 853: 856.
  4. Madalinski MH, Slawek J, Zbytek B, et al. Topical nitrates and the higher doses of botulinum toxin for chronic anal fissure. Hepatogastroenterology. 2001; 48(40): 977–979.
  5. Ahmadi J, Azary S, Ashjaei B, et al. Intrasphincteric botulinum toxin injection in treatment of chronic idiopathic constipation in children. Iran J Pediatr. 2013; 23(5): 574–578.
  6. Wester T, Granström AL. Botulinum toxin is efficient to treat obstructive symptoms in children with Hirschsprung disease. Pediatr Surg Int. 2015; 31(3): 255–259.
  7. Wald A, Bharucha AE, Cosman BC, et al. ACG clinical guideline: management of benign anorectal disorders. Am J Gastroenterol. 2014; 109(8): 1141–57; (Quiz) 1058.
  8. Emile SH, Elfeki HA, Elbanna HG, et al. Efficacy and safety of botulinum toxin in treatment of anismus: A systematic review. World J Gastrointest Pharmacol Ther. 2016; 7(3): 453–462.
  9. Zhang Y, Wang ZN, He L, et al. Botulinum toxin type-A injection to treat patients with intractable anismus unresponsive to simple biofeedback training. World J Gastroenterol. 2014; 20(35): 12602–12607.
  10. Cuda T, Gunnarsson R, de Costa A. Symptoms and diagnostic criteria of acquired Megacolon - a systematic literature review. BMC Gastroenterol. 2018; 18(1): 25.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl